Literature DB >> 16148125

NF-kappaB couples protein kinase B/Akt signaling to distinct survival pathways and the regulation of lymphocyte homeostasis in vivo.

Russell G Jones1, Sam D Saibil, Joyce M Pun, Alisha R Elford, Madeleine Bonnard, Marc Pellegrini, Sudha Arya, Michael E Parsons, Connie M Krawczyk, Steve Gerondakis, Wen-Chen Yeh, James R Woodgett, Mark R Boothby, Pamela S Ohashi.   

Abstract

Protein kinase B (PKBalpha/Akt1) a PI3K-dependent serine-threonine kinase, promotes T cell viability in response to many stimuli and regulates homeostasis and autoimmune disease in vivo. To dissect the mechanisms by which PKB inhibits apoptosis, we have examined the pathways downstream of PKB that promote survival after cytokine withdrawal vs Fas-mediated death. Our studies show that PKB-mediated survival after cytokine withdrawal is independent of protein synthesis and the induction of NF-kappaB. In contrast, PKB requires de novo gene transcription by NF-kappaB to block apoptosis triggered by the Fas death receptor. Using gene-deficient and transgenic mouse models, we establish that NF-kappaB1, and not c-Rel, is the critical signaling molecule downstream of the PI3K-PTEN-PKB signaling axis that regulates lymphocyte homeostasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148125     DOI: 10.4049/jimmunol.175.6.3790

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

2.  CARMA1 is required for Akt-mediated NF-kappaB activation in T cells.

Authors:  Preeti Narayan; Brittany Holt; Richard Tosti; Lawrence P Kane
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

3.  Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway.

Authors:  Luting Xu; Li Zhang; Anne M Bertucci; Richard M Pope; Syamal K Datta
Journal:  Immunol Lett       Date:  2008-09-21       Impact factor: 3.685

4.  Micropatterning of costimulatory ligands enhances CD4+ T cell function.

Authors:  Keyue Shen; V Kaye Thomas; Michael L Dustin; Lance C Kam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-27       Impact factor: 11.205

5.  Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Authors:  Valentina Di Caro; Antonella D'Anneo; Brett Phillips; Carl Engman; Jo Harnaha; Massimo Trucco; Nick Giannoukakis
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

6.  Phosphorylated insulin-like growth factor-1 receptor expression predicts poor prognosis of Chinese patients with gastric cancer.

Authors:  Wen-ying Deng; Ning Li; Xiang-bin Wan; Su-xia Luo; You-wei Zhang
Journal:  Med Oncol       Date:  2014-10-28       Impact factor: 3.064

7.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

8.  Akt fine-tunes NF-κB-dependent gene expression during T cell activation.

Authors:  Jing Cheng; Binh Phong; David C Wilson; Raphael Hirsch; Lawrence P Kane
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

Review 9.  The significance of OX40 and OX40L to T-cell biology and immune disease.

Authors:  Michael Croft; Takanori So; Wei Duan; Pejman Soroosh
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

10.  Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival.

Authors:  Hirozumi Sawai; Akira Yasuda; Nobuo Ochi; Jiachi Ma; Yoichi Matsuo; Takehiro Wakasugi; Hiroki Takahashi; Hitoshi Funahashi; Mikinori Sato; Hiromitsu Takeyama
Journal:  BMC Gastroenterol       Date:  2008-11-26       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.